PVLA
Palvella Therapeutics
PVLA
PVLA
49 hedge funds and large institutions have $8.04M invested in Palvella Therapeutics in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
65% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 17
76% less capital invested
Capital invested by funds: $33.4M → $8.04M (-$25.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
49
Holding in Top 10
–
Calls
$21K
Puts
$1K
Top Buyers
| 1 | +$2.57M | |
| 2 | +$1.04M | |
| 3 | +$448K | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$159K |
| 5 |
CM
CM Management
Gulf Breeze,
Florida
|
+$91K |
Top Sellers
| 1 | -$4.04M | |
| 2 | -$2.22M | |
| 3 | -$952K | |
| 4 |
Walleye Capital
New York
|
-$467K |
| 5 |
CCB
Cutter & Co Brokerage
Ballwin,
Missouri
|
-$370K |